Jorge Moll Filho is a Brazilian entrepreneur and cardiologist who resides in Rio de Janeiro. In 1977, he found a health diagnostics imaging lab that evolved into being one of the largest lab operators and hospitals in Brazil. In 2010, Moll sold to the publicly-traded, Fleury SA, the subsidiary labs, Rede D’Or, which owns over 30 hospitals, for over $750 million. Fleury SA is a medical services provider in Brazil. During the same year, Moll also acquired the Sao Luiz, which is a hospital group based in Sao Paulo (idor.org). Other business transactions he encountered include the purchasing of stakes in the Brazilian hospital operator by GIC Pte. Ltd., a sovereign-wealth fund in Singapore, and by Carlyle Group, a private equity firm, in 2015. Also, approximately 12% of Rede D’or was sold in December 2015 by the Brazilian bank, BTC Pactual for about $595 million.
In Recent News
A report was made in May 2017 concerning the technology role in the advancement of medicine. Jorge Moll, who is the president of D’or Institute for Research and Teaching, stated that patient treatment and care can be revolutionized with the alliance of innovation to health.
This alliance is an increasingly global trend. As a matter of fact, it’s almost impossible to discuss the advances in medicine without referring to the benefits which technology has been providing to the industry. In the US, particularly the Silicon Valley and surrounding areas in northern California, there is now an overflow of digital technology into healthcare; thus, creating new horizons in the industry. And as a result, several benefits have occurred, including a more humanized and efficient interaction between patients and physicians, a 100% focus on the patient since the physician doesn’t have to divide his/her time by taking notes or consulting files, greater medical evaluation depth and safety, and all information collected at the end of the consultation is remotely structured and reviewed by the specialist that enabled improved patient experience and increased productivity.
With these initiatives and more, the present and future of medicine can greatly assist different health sectors in Brazil. This will include hospital networks, individual developers, entrepreneurs, startups, public and private teaching and research institutions, and venture capitalists in and for Brazil.
More at http://www.abc.org.br/~JMOLL